Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on immune and cellular therapy in multiple myeloma.

Holstein, Sarah A; Asimakopoulos, Fotis; Azab, Abdel Kareem; Bianchi, Giada; Bhutani, Manisha; Crews, Leslie A; Cupedo, Tom; Giles, Hannah; Gooding, Sarah; Hillengass, Jens; John, Lukas; Kaiser, Shari; Lee, Lydia; Maclachlan, Kylee; Pasquini, Marcelo C; Pichiorri, Flavia; Shah, Nina; Shokeen, Monica; Shy, Brian R; Smith, Eric L; Verona, Raluca; Usmani, Saad Z; McCarthy, Philip L

Name:

Publisher version

Abstract

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.

Citation

Holstein SA, Asimakopoulos F, Azab AK, Bianchi G, Bhutani M, Crews LA, Cupedo T, Giles H, Gooding S, Hillengass J, John L, Kaiser S, Lee L, Maclachlan K, Pasquini MC, Pichiorri F, Shah N, Shokeen M, Shy BR, Smith EL, Verona R, Usmani SZ, McCarthy PL. Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma. Transplant Cell Ther. 2022 Aug;28(8):446-454. doi: 10.1016/j.jtct.2022.05.019. Epub 2022 May 21

Type

Article